Product Information
VARDENAFIL HCL 10 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $2.8666 per EA under NDC 00527280232. Its NADAC has been published 234 times since May 22, 2019.
FDA first approved this application on Oct 31, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Lannett Company Inc.NDC
00527280232
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VARDENAFIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209057FDA Approved
10/31/2018
TE Code
AB
On Market Since
11/1/2018
Pharmacological Classes
Price Statistics
The NADAC for VARDENAFIL HCL 10 MG TABLET has been published 234 times since May 22, 2019, and over the history we have for it it has declined 87.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8666 per EA |
|---|---|
| All-time high | $23.0531 (May 13, 2020) |
| All-time low | $1.7986 (Jul 22, 2026) |
| 52-week high | $2.9931 |
| 52-week low | $1.7986 |
| Median price | $3.9127 |
| Average price | $8.5623 |
| Largest weekly change | -62.9% (Aug 17, 2022) |
| Weeks tracked | 234 |
| Tracking since | May 22, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Vardenafil Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VARDENAFIL HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VARDENAFIL HCL 10 MG TABLET, manufactured by Lannett Company Inc., is $2.8666 per EA (NDC 00527280232), effective Sep 30, 2026.
How has the price of VARDENAFIL HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for VARDENAFIL HCL 10 MG TABLET has declined 87.6%. It has been tracked across 234 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for VARDENAFIL HCL 10 MG TABLET?
Since May 22, 2019, the NADAC for VARDENAFIL HCL 10 MG TABLET has ranged from a low of $1.7986 (Jul 22, 2026) to a high of $23.0531 (May 13, 2020), with a median of $3.9127 per EA.
Are there cheaper alternatives to VARDENAFIL HCL 10 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VARDENAFIL HCL 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VARDENAFIL HCL 10 MG TABLET?
VARDENAFIL HCL 10 MG TABLET (NDC 00527280232) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.